The Journal of Urology
Volume 183, Issue 4 , Pages 1366-1372 , April 2010

Comparative Effectiveness of Prostate Cancer Surgical Treatments: A Population Based Analysis of Postoperative Outcomes

Received 25 July 2009

References 

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71
  2. Guillonneau B, Vallancien G. Laparoscopic radical prostatectomy: the Montsouris experience. J Urol. 2000;163:418
  3. Schuessler WW, Kavoussi LR, Clayman RV, et al. Laparoscopic radical prostatectomy: initial case report. J Urol. 1992;147:246A
  4. Schuessler WW, Schulam PG, Clayman RV, et al. Laparoscopic radical prostatectomy: initial short-term experience. Urology. 1997;50:854
  5. Abbou CC, Hoznek A, Salomon L, et al. Remote laparoscopic radical prostatectomy carried out with a robot (Report of a case). Prog Urol. 2000;10:520
  6. Binder J, Kramer W. Robotically-assisted laparoscopic radical prostatectomy. BJU Int. 2001;87:408
  7. Menon M, Tewari A, Peabody JO, et al. Vattikuti Institute prostatectomy, a technique of robotic radical prostatectomy for management of localized carcinoma of the prostate: experience of over 1100 cases. Urol Clin North Am. 2004;31:701
  8. Guazzoni G, Cestari A, Naspro R, et al. Intra- and peri-operative outcomes comparing radical retropubic and laparoscopic radical prostatectomy: results from a prospective, randomised, single-surgeon study. Eur Urol. 2006;50:98
  9. Ficarra V, Novara G, Artibani W, et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol. 2009;55:1037
  10. Hu JC, Hevelone ND, Ferreira MD, et al. Patterns of care for radical prostatectomy in the United States from 2003 to 2005. J Urol. 2008;180:1969
  11. Hu JC, Wang Q, Pashos CL, et al. Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol. 2008;26:2278
  12. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40:IV
  13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373
  14. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40:IV
  15. Guillonneau B, Rozet F, Cathelineau X, et al. Perioperative complications of laparoscopic radical prostatectomy: the Montsouris 3-year experience. J Urol. 2002;167:51
  16. Smith JA, Herrell SD. Robotic-assisted laparoscopic prostatectomy: do minimally invasive approaches offer significant advantages?. J Clin Oncol. 2005;23:8170
  17. Eastham JA, Kattan MW, Rogers E, et al. Risk factors for urinary incontinence after radical prostatectomy. J Urol. 1996;156:1707
  18. Lotan Y, Cadeddu JA, Gettman MT. The new economics of radical prostatectomy: cost comparison of open, laparoscopic and robot assisted techniques. J Urol. 2004;172:1431
  19. Scales CD, Jones PJ, Eisenstein EL, et al. Local cost structures and the economics of robot assisted radical prostatectomy. J Urol. 2005;174:2323
  20. Nelson B, Kaufman M, Broughton G, et al. Comparison of length of hospital stay between radical retropubic prostatectomy and robotic assisted laparoscopic prostatectomy. J Urol. 2007;177:929
  21. Wood DP, Schulte R, Dunn RL, et al. Short-term health outcome differences between robotic and conventional radical prostatectomy. Urology. 2007;70:945
  22. Pruthi RS, Wallen EM. Current status of robotic prostatectomy: promises fulfilled. J Urol. 2009;181:2420
  23. Schroeck FR, Krupski TL, Sun L, et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol. 2008;54:785
  24. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med. 2002;346:1138
  25. Initial National Priorities for Comparative Effectiveness Research (Committee on Comparative Effectiveness Research Prioritization). Washington, D. C: Institute of Medicine; 2009;

 Supported by National Institutes of Health 1RC1CA146516-01 (JAE, EBE, WTL, DSY), T32-CA82088 (PTS, WTL), National Cancer Institute P50-CA92629 SPORE (PTS) and CA118189-01A2 (EBE), Sidney Kimmel Center for Prostate and Urologic Cancers, David H. Koch provided through the Prostate Cancer Foundation and Memorial Sloan-Kettering Cancer Center.

 Supplementary material for this article can be obtained at http://www.mskcc.org/comparative-effectiveness-prostate-cancer/journalofurology.

 For other articles on a related topic see pages 1598 and 1619.

PII: S0022-5347(09)03185-1

doi: 10.1016/j.juro.2009.12.021

The Journal of Urology
Volume 183, Issue 4 , Pages 1366-1372 , April 2010

Article Tools

* Image Usage & Resolution